- Risperidone
Drug Information
Ingredients:
Drug Brands and Names:
- Risperdal
- Risperdal Consta
- Risperdal M-tab
- Risperidone
- Risperidone M-tab
- Risperidone Oral Disintegrate Tablets
Manufacturers:
- American Health Packaging
- Cardinal Health
- Janssen Pharmaceutical, Inc.
- Janssen Pharmaceuticals Inc
- Janssen Pharmaceuticals, Inc.
- Ranbaxy Pharmaceuticals Inc.
Approved Uses (Extracted from drug label):
- No data available
Common Uses (Extracted from FDA adverse event reports):
- Product used for unknown indication (27%)
- Schizophrenia (20%)
- Psychotic disorder (7%)
- Bipolar disorder (5%)
- Depression (5%)
- Schizoaffective disorder (3%)
- Schizophrenia, paranoid type (3%)
- Anxiety (2%)
- Agitation (2%)
- Ill-defined disorder (1%)
- Aggression (1%)
- Abnormal behaviour (1%)
- Dementia (1%)
- Obsessive-compulsive disorder (1%)
Side Effect Information
Preferred Term: Breast Enlargement
Additional Terms:
- Enlarged breasts
- Grow belly and breasts
- Breast changes
- Larger breasts
- Breast development
- My "barely B" breast size had grown to a "double D"
- Breast are huge
- Breasts might get larger
- Breast grew
- Larger 'breasts'
- Breast enlarged
- Boob job
- Breast formation
- Breast enlarged and hard
- Increased breast size
- Hypertrophy breast
- Boobs have grown
- Breasts are increased
- Enlargement of my breasts
- Breast got very large
- Breast growth
- boobs got a little bigger
- breasts definitely grew half a cup size
- Bigger boobs
- man boobs may have gotten larger
- Breast tenderness and enlargement
- Boobs were getting bigger
- Enlarged (slightly so far) right breast
- Bra size went up 2 full cup sizes
- Went up 2 full cup sizes
- Boobs might have gotten slightly bigger
- My breast are huge
Date Filter
AERS Report Filter
Death
Life-threatening
Disability
Hospitalization
Congenital Anomaly
Other
Risperidone Related Breast Enlargement
Report is for all products sharing this active ingredient. Use the workbench for research on individual brands like Risperdal.- Official FDA
Reports - Social Media
Reports
Risperidone Related Breast Enlargement Age and Gender Distribution (From AERS Data)
Trends in Risperidone Related Breast Enlargement Adverse Event Reports
- AERS Reports (FDA)
- Social Media Reports
Risperidone Related Breast Enlargement Reports (From AERS Data)
* "-" Indicates fields that were not specified in report recieved by the FDA.
Risperidone Related Breast Enlargement Reports (From Social Media - User Reviews and Forum Discussions)
* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.
* About AERS: The Adverse Event Reporting System (AERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into AERS. The AERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, AERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.
* About AERS: The Adverse Event Reporting System (AERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into AERS. The AERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, AERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.
The total number of adverse event reports in the FDA-owned Adverse Event Reporting System (AERS).
The total number of adverse event reports extracted from online social media sources (forum discussions, user reviews, etc).